1 0

    FDA FAERS Reports on Retinal Vasculitis and All Safety Reports for Izervay and Syfovre

    FDA FAERS Reports on Retinal Vasculitis and All Safety Reports for Izervay and Syfovre

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Please look at the FAERS data/FOIA Post-Market Safety Cases that have been reported for Izervay and Syfovre. Notably, we are interested in occurrences of "retinal vasculitis," but please include all safety reports.
    Tags: Pharma, FAERS, 2025
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

    View full details